Ocera Reports Fourth Quarter and Full Year 2014 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Ocera Therapeutics (OCRX) Tops Q4 EPS by 18c
March 11, 2015 4:25 PM EDTOcera Therapeutics (NASDAQ: OCRX) reported Q4 EPS of ($0.28), $0.18 better than the analyst estimate of ($0.46).
For earnings history and earnings-related data on Ocera Therapeutics (OCRX) click here.
... More